Exercise participation barrier prevalence and association with exercise participation status in individuals with spinal cord injury

Spinal Cord
R E CowanK D Anderson

Abstract

Pass-code protected web survey. Defining exercise participation barrier prevalence and association with exercise participation status in adults with spinal cord injury (SCI). World-wide web. Individuals ≥18 years with ShCI in the United States completed a pass-code protected website survey (N=180). Odds ratios (OR) and OR 95% confidence interval (95% CI) assessed association between barrier presence and exercise participation. No differences existed between exercisers and non-exercisers with respect to age, gender, injury level, injury duration, education level, or employment status. A larger percentage of non-exercisers reported household annual incomes <$7,500. The five most prevalent barriers were not associated with participation status (all OR 95% CI included 1). Low prevalence (≤13%) characterized four of the five barriers most strongly related to being a non-exerciser. Identifying too lazy, too difficult, or no interest as a barrier decreased odds of being an exerciser by 86%, 83%, and 71%, respectively. Not liking exercise decreased the odds of being an exerciser by 90%. Highly prevalent barriers were not associated with exercise participation status, whereas low prevalence barriers were strongly related to being a non-...Continue Reading

Associated Clinical Trials

Oct 26, 2017·Linda Ehrlich-Jones

References

Mar 10, 1999·Disability and Rehabilitation·S KinneE J Maher
Feb 11, 2000·Archives of Physical Medicine and Rehabilitation·J H RimmerD Braddock
Aug 15, 2000·Annual Review of Nutrition·N E Sherwood, R W Jeffery
May 29, 2004·American Journal of Preventive Medicine·James H RimmerJanine Jurkowski
Jul 22, 2005·American Journal of Physical Medicine & Rehabilitation·William M ScelzaDenise G Tate
May 4, 2010·Archives of Physical Medicine and Rehabilitation·Kathleen A Martin GinisDalton L Wolfe

❮ Previous
Next ❯

Citations

May 7, 2013·Archives of Physical Medicine and Rehabilitation·Mara B NeryKerri A Vanderbom
Jan 24, 2015·The Journal of Spinal Cord Medicine·Ashraf S GorgeyRefka E Khalil
Mar 29, 2016·Disability and Rehabilitation·Erik C ProutDina Brooks
Sep 3, 2014·Spinal Cord·C A PelletierA L Hicks
Feb 11, 2015·Nature Reviews. Urology·Sandra M Gomez-AmayaMichael R Ruggieri
Jun 11, 2019·The Journal of Spinal Cord Medicine·Mark S NashAllen J Taylor
Jan 7, 2014·Medicine and Science in Sports and Exercise·Jochen KresslerMark S Nash
Jan 18, 2018·Topics in Spinal Cord Injury Rehabilitation·Jennifer L MaherMark S Nash
Sep 25, 2020·The Journal of Spinal Cord Medicine·Michael TodorovicJenny Ekberg
Dec 14, 2018·Current Physical Medicine and Rehabilitation Reports·Mark S Nash, James L J Bilzon
Jun 6, 2017·JMIR Rehabilitation and Assistive Technologies·Byron LaiC Scott Bickel
Nov 22, 2018·Topics in Spinal Cord Injury Rehabilitation·Mark S NashUNKNOWN Consortium for Spinal Cord Medicine
Jul 17, 2019·African Journal of Disability·Mokgadi K Mashola, Diphale J Mothabeng
Oct 23, 2020·Archives of Physical Medicine and Rehabilitation·Rasmus K HansenRachel E Cowan
Jul 7, 2020·Physical Medicine and Rehabilitation Clinics of North America·Mark S Nash, David R Gater
Dec 18, 2019·Experimental Neurology·Ona BloomAnn M Spungen
Apr 6, 2021·Topics in Spinal Cord Injury Rehabilitation·Andrea C BettsKatherine Froehlich-Grobe
Oct 1, 2021·International Journal of Sport Nutrition and Exercise Metabolism·Soraya Martín-ManjarrésIgnacio Ara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.